arrow
N

Norifumi Hattori

Department of Gastroenterological Surgery
H指数:18
被引数:1,299

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

BBS5 as a robust prognostic biomarker in esophageal squamous cell carcinoma: validation in two independent cohorts

BBS5作为食管鳞状细胞癌中一个稳健的预后生物标志物:在两个独立队列中的验证

2026-08-180
PRE
Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (study rindo)

日本转移性结直肠癌患者中,FOLFIRI联合低剂量伊立替康与雷莫芦单抗作为二线治疗的II期研究(研究rindo)

2025-12-010
OA
Overexpression of cat eye syndrome chromosome region, candidate 2 in esophageal squamous carcinoma cell promotes tumor aggressiveness by facilitating NF-κB signaling and inhibition of p53-associated apoptosis

食道鳞状细胞癌细胞中猫眼综合征染色体区域候选2基因的过表达通过促进NF-κB信号通路和抑制p53相关凋亡来增强肿瘤侵袭性。

2025-08-040
PRE
SPOCD1 Enhances Cancer Cell Activities and Serves as a Prognosticator in Esophageal Squamous Cell Carcinoma

SPOCD1增强食管鳞状细胞癌中癌细胞活性并作为预后指示因子

2025-02-240
OA
ASO Visual Abstract: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9
2022-07-021
PRE